A citation-based method for searching scientific literature

Lingzhi Hong, Jianjun Zhang, John V Heymach, Xiuning Le. Ther Adv Med Oncol 2021
Times Cited: 21



Mark A Socinski, Nathan A Pennell, Kurtis D Davies. JCO Precis Oncol 2021
Times Cited: 24




List of shared articles



Times cited

Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program.
Oliver Illini, Hannah Fabikan, Aurélie Swalduz, Anders Vikström, Dagmar Krenbek, Michael Schumacher, Elizabeth Dudnik, Michael Studnicka, Ronny Öhman, Robert Wurm,[...]. Ther Adv Med Oncol 2022
2


Integrative genomic analysis of drug resistance in MET exon 14 skipping lung cancer using patient-derived xenograft models.
Yunhua Xu, Linping Gu, Yingqi Li, Ruiying Zhao, Hong Jian, Wenhui Xie, Liu Liu, Huiwen Wu, Fang Ren, Yuchen Han,[...]. Front Oncol 2022
0

KRAS and MET in non-small-cell lung cancer: two of the new kids on the 'drivers' block.
Juan Esteban Garcia-Robledo, Rafael Rosell, Alejandro Ruíz-Patiño, Carolina Sotelo, Oscar Arrieta, Lucia Zatarain-Barrón, Camila Ordoñez, Elvira Jaller, Leonardo Rojas, Alessandro Russo,[...]. Ther Adv Respir Dis 2022
2


New Targeted Therapy for Non-Small Cell Lung Cancer.
Eun Ki Chung, Seung Hyun Yong, Eun Hye Lee, Eun Young Kim, Yoon Soo Chang, Sang Hoon Lee. Tuberc Respir Dis (Seoul) 2023
0

Clinical and pathological characteristics of 11 NSCLC patients with c-MET exon 14 skipping.
Hualin Chen, Yipin Luo, Muwen Lin, Huoguang Chen, Meilian Liu, Yongcun Wang, Shujun Li, Donghong Yang, Zhixiong Yang. Transl Cancer Res 2022
1